Cargando…

EPO pre-treatment for haemorrhagic shock

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Limited 2013
Materias:	In This Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634633/

Ejemplares similares

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

EPOS Abstract Book
Publicado: (2022)

Welcome to EPOS 2023
por: Sanpera, Ignacio, et al.
Publicado: (2023)

EPOS Abstract Book
Publicado: (2023)

How to pursue EPO in MS
por: Bartels, Claudia, et al.
Publicado: (2017)

Shocking localization
por: LeBrasseur, Nicole
Publicado: (2002)

Interferin' with shock
por: Maxmen, Amy
Publicado: (2009)

r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
por: Tapolyai, Mihály, et al.
Publicado: (2003)

Life after shock
por: Maxmen, Amy
Publicado: (2009)

Isinglass Transfusion for Hæmorrhage and Shock
Publicado: (1943)

Reduced EPO receptor expression may contribute to limited pleiotropic effects of EPO during critical illness
por: McCook, O, et al.
Publicado: (2012)

Lulling septic shock to sleep
por: Van Epps, Heather L.
Publicado: (2006)

An evaluation of the EPOS selective chemistry analyser
por: Hughes, G. J., et al.
Publicado: (1987)

Erythropoietin (EPO) in acute kidney injury
por: Moore, Elizabeth, et al.
Publicado: (2011)

EPOS 33rd Annual Meeting
Publicado: (2014)

EPOS 33rd Annual Meeting
Publicado: (2014)

EPOS 33rd Annual Meeting
Publicado: (2014)

EPOS 35th Congress Meeting
Publicado: (2016)

EPOS 35th Congress Meeting
Publicado: (2016)

EPOS 35th Congress Meeting
Publicado: (2016)

EPOS 34th Annual Meeting
Publicado: (2015)

EPOS 34th Annual Meeting
Publicado: (2015)

EPOS 34th Annual Meeting
Publicado: (2015)

Author Index EPOS, 2015, France
Publicado: (2015)

Finding a heat-shock absorber
por: Dove, Alan W.
Publicado: (2002)

Shock therapy: modulating stem cells
Publicado: (2011)

Therapy of an incomplete spinal cord injury by intrathecal injection of EPO and subcutaneous injection of EPO, vitamin C and G-CSF
por: Bader, Augustinus, et al.
Publicado: (2017)

Pre-hospital plasma in haemorrhagic shock management: current opinion and meta-analysis of randomized trials
por: Coccolini, Federico, et al.
Publicado: (2019)

An evaluation of the Eppendorf EPOS 5060 biochemistry autoanalyser
por: Antoja, F., et al.
Publicado: (1987)

Potential of Novel EPO Derivatives in Limb Ischemia
por: Joshi, Dhiraj, et al.
Publicado: (2012)

Author Index EPOS, 2016, Rome, Italy
Publicado: (2016)

EPOS: EEG Processing Open-Source Scripts
por: Rodrigues, Johannes, et al.
Publicado: (2021)

Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
por: Soliz, Jorge, et al.
Publicado: (2020)

Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
por: Kittur, Farooqahmed S., et al.
Publicado: (2023)

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
por: Chen, Zhimin, et al.
Publicado: (2018)

Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
por: Bläsius, Felix Marius, et al.
Publicado: (2023)

Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia
por: Major, Tamás, et al.
Publicado: (2019)

Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients
por: Takasawa, Kazuya, et al.
Publicado: (2014)

EPO‐receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis
por: Lamon, Séverine, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b6cs7prdppaml1kgsi4b3nst61